Key points are not available for this paper at this time.
Design
Review
Highlights urgent need for therapies; leaves open identification of effective targets in human studies.
C ardiovascular calcification is a growing burden and a leading predictor of and contributor to acute cardiovascular events. Arterial calcification associates with a 4-fold increase in cardiovascular events, and patients with aortic valve calcification have a 5-year event-free survival rate of only 26%, 1,2 worse than that of many cancers. Despite massive healthcare costs and extensive research efforts, effective therapeutic strategies remain elusive. Cardiovascular calcification, often generalized as one disease, is in reality a multifaceted disorder that occurs in diverse milieus as a result of multiple, interacting pathogenic processes. Herein, we explore these variables and propose a set of guidelines for studying cardiovascular calcification.
No takes yet. Share an insight, caveat, or question.
Hutcheson et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: